Alcon showcases new data at APACRS 2025, emphasizing advancements in IOL technology and surgical precision for improved ...

We recently published 10 Stocks Crash as AI Glow Fades. Alcon Inc. (NYSE:ALC) is one of Wednesday’s worst performers. Shares of Alcon Inc. snapped a six-day winning streak on Wednesday, losing 10.07 ...

ALC's Q2 earnings top estimates but revenues fall short, sending shares down more than 10% as margins tightened and 2025 sales outlook narrowed.

Tom McDonald worked at Alcon for nearly four decades and writes about the eyecare giant's remarkable growth that started in ...

Alcon (NYSE:ALC) stock continues to decline as J.P. Morgan downgrades the company following mixed Q2 2025 results and lowered sales guidance. Read more here.

Alcon affirmed fiscal year 2025 adjusted earnings of $3.05-$3.15 versus consensus of $3.12. The company lowered 2025 sales guidance from $10.4 billion-$10.5 billion to $10.3 billion-$10.4 billion, ...

The analysts cut its rating on Alcon shares to “neutral” from “overweight” and lowered its price target to SFr 62.8 for June 2027, down from SFr 94.7 for June 2026. The reduced target reflects lower ...

Alcon India unveils UNITY VCS and UNITY CS with superior efficiency for vitreoretinal and cataract surgery: Our Bureau, Bengaluru Thursday, August 21, 2025, 14:40 Hrs [IST] Alcon, ...

Alcon AG (NYSE:ALC) saw its stock fall more than 2% on Thursday following a rating cut by J.P. Morgan, citing disappointing ...

Walmart (NYSE: WMT) stock fell 2.7% after the retail giant reported mixed second-quarter results, with revenue exceeding expectations but earnings falling short of analyst estimates. The retail giant ...

Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access.

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that the Company will participate in the 2025 Wells Fargo Healthcare Conference. Company management ...